ClinVar Miner

Submissions for variant NM_007294.4(BRCA1):c.4126A>G (p.Thr1376Ala)

gnomAD frequency: 0.00001  dbSNP: rs576828558
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV001021919 SCV001183595 uncertain significance Hereditary cancer-predisposing syndrome 2018-04-12 criteria provided, single submitter clinical testing The p.T1376A variant (also known as c.4126A>G), located in coding exon 10 of the BRCA1 gene, results from an A to G substitution at nucleotide position 4126. The threonine at codon 1376 is replaced by alanine, an amino acid with similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Invitae RCV001862197 SCV002126562 uncertain significance Hereditary breast ovarian cancer syndrome 2023-09-15 criteria provided, single submitter clinical testing In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt BRCA1 protein function. ClinVar contains an entry for this variant (Variation ID: 824612). This variant has not been reported in the literature in individuals affected with BRCA1-related conditions. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 1376 of the BRCA1 protein (p.Thr1376Ala).
CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario RCV003492209 SCV004240264 uncertain significance Breast and/or ovarian cancer 2023-03-01 criteria provided, single submitter clinical testing
Center for Precision Medicine, Meizhou People's Hospital RCV002250716 SCV002520861 uncertain significance Familial cancer of breast no assertion criteria provided curation

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.